While the presence of mutations in both PTCH1 and SMO genes is central to the development of BCC, the precise mechanisms through which upregulation of the Hh pathway contributes to tumorigenesis remain complex. The gene discussed is PTCH1; the disease is skin basal cell carcinoma.